A clinical study to see the effect of an Ayurvedic formulation in the treatment of Chronic Simple Rhinitis(common cold).

Randomized comparative cinical trial to study the effficacy of Katphaladi Churna and Tablet Levocetrizine[5mg] with Montelukast [10mg] in Peenasa Vyadhi.

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/023837

Enrollment

Registered

2020-03-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J310- Chronic rhinitis

Interventions

Intervention1: Katphaladi Churna: Katphaladi churna, Orally 1 gm,(In two equal divided doses) with Koshna Jala (lukewarm water)for 15 days Control Intervention1: Levocetrizine, Montelukast: Levocetriz

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients from age group of 20 to 50 years. 2) Patients irrespective of gender and religion. 3) Patients having signs and signs and symptoms of Peenasaa Vyadhi(Chronic SimpleRhinitis) like Nasal Obstruction, Post-Nasal Drip, Partial loss of Smell(Anosmia).

Exclusion criteria

Exclusion criteria: 1) Patients suffering from known case of chronic specific infective rhinitis like Syphilis, leprosy, T.B. lupus Vulgaris, Rhinosporidiosis, Rhinoscleroma, fungal Infections, leishmaniasis. 2) Patients with systemic diseases and known case of Hypertension, Respiratory disorder, Diabetes Mellitus, HBsAg, HIV. 3) Patients with DNS, Nasal polyp, Asthma, Tumors or any nasal pathology. 4) Patient not willing for treatment and irregular follow up.

Design outcomes

Primary

Measure	Time frame
A clinical study to evaluate efficacy of Katphaladi Churna in Peenasa Vyadhi w.r.t Chronic Simple RhinitisTimepoint: The drug will be given 15 days. The patients will be assessed before and after treatment. Total duration of the study will 18 months.	—

Secondary

Measure	Time frame
A comparison between efficacy of Katphaladi Churna and Tab Levocetrizine 5mg in combination with Montelukast 10mg in Peenasa Vyadhi w.r.t Chronic Simple RhinitisTimepoint: Total duration of study is 18 Months	—

Countries

India

Contacts

Public ContactDr Pravin Madhukar Bhat

Sumatibhai Shah Ayurved Mahavidyalaya

vdpravin82@gmail.com9860233173

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026